SecSonar.com

TELA Bio, Inc. (TELA)

TELA Bio, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

TELA Bio, Inc. (TELA) is a Medical - Devices company based in US with a market capitalization of $42.5M. Revenue grew 15.8% year-over-year and free cash flow was negative at -$28.7M. This page tracks TELA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 209 employees · IPO Nov 8, 2019

Valuation

Valuation & price

$0.91 · as of May 17, 2026 · -57.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

6.74

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.14$1.35$0.56Jul 25Dec 25Jul 26Jul 7, 25$1.93Jul 9, 25$2.14Jul 11, 25$2.00Jul 15, 25$2.01Jul 17, 25$1.98Jul 21, 25$1.98Jul 23, 25$1.94Jul 25, 25$1.92Jul 29, 25$1.98Jul 31, 25$1.70Aug 4, 25$1.85Aug 6, 25$1.70Aug 11, 25$1.86Aug 13, 25$1.47Aug 15, 25$1.58Aug 19, 25$1.74Aug 21, 25$1.72Aug 25, 25$1.83Aug 27, 25$1.76Aug 29, 25$1.78Sep 3, 25$1.65Sep 5, 25$1.59Sep 9, 25$1.60Sep 11, 25$1.62Sep 16, 25$1.58Sep 18, 25$1.59Sep 22, 25$1.61Sep 24, 25$1.55Sep 26, 25$1.45Sep 30, 25$1.49Oct 2, 25$1.51Oct 6, 25$1.52Oct 8, 25$1.53Oct 10, 25$1.46Oct 14, 25$1.49Oct 16, 25$1.50Oct 21, 25$1.51Oct 23, 25$1.49Oct 27, 25$1.48Oct 29, 25$1.32Oct 31, 25$1.23Nov 4, 25$1.29Nov 6, 25$1.18Nov 10, 25$1.19Nov 12, 25$1.14Nov 14, 25$1.00Nov 18, 25$1.18Nov 20, 25$1.06Nov 25, 25$1.14Nov 28, 25$1.15Dec 2, 25$1.14Dec 4, 25$1.14Dec 8, 25$1.13Dec 10, 25$1.17Dec 12, 25$1.15Dec 16, 25$1.18Dec 18, 25$1.14Dec 22, 25$1.14Dec 24, 25$1.14Dec 29, 25$1.10Jan 2, 26$1.14Jan 6, 26$1.14Jan 8, 26$1.09Jan 12, 26$1.06Jan 14, 26$1.01Jan 16, 26$1.02Jan 21, 26$0.97Jan 23, 26$0.98Jan 27, 26$0.98Jan 29, 26$0.97Feb 2, 26$0.94Feb 4, 26$0.84Feb 9, 26$0.81Feb 11, 26$0.82Feb 13, 26$0.79Feb 18, 26$0.78Feb 20, 26$0.72Feb 24, 26$0.79Feb 26, 26$0.82Mar 2, 26$0.86Mar 4, 26$0.84Mar 6, 26$0.90Mar 10, 26$0.84Mar 12, 26$0.77Mar 17, 26$0.80Mar 19, 26$0.75Mar 23, 26$0.83Mar 25, 26$0.69Mar 27, 26$0.67Mar 31, 26$0.62Apr 2, 26$0.60Apr 7, 26$0.69Apr 9, 26$0.60Apr 13, 26$0.56Apr 15, 26$0.66Apr 17, 26$0.68Apr 22, 26$0.62Apr 24, 26$0.67Apr 28, 26$0.78Apr 30, 26$0.87May 4, 26$1.09May 6, 26$0.99May 8, 26$1.02May 12, 26$1.02May 14, 26$0.99May 18, 26$0.83May 20, 26$0.95May 22, 26$0.89May 28, 26$0.90Jun 1, 26$0.90Jun 3, 26$0.86Jun 5, 26$0.88Jun 9, 26$0.94Jun 11, 26$0.91Jun 15, 26$0.80Jun 17, 26$0.86Jun 22, 26$0.81Jun 24, 26$0.75Jun 26, 26$0.71Jul 2, 26$0.72
$0.5652-week range$2.14
Loading valuation history…

Fundamentals

Key fundamentals

$42.5M

Market cap

15.8%

Revenue growth (YoY)

67.7%

Gross margin

-$28.7M

Free cash flow (USD)

$4.8M

Net debt

64.6%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$4.2MFY 2018$8.3MFY 2019$15.4MFY 2020$18.2MFY 2021$29.5MFY 2022$41.4MFY 2023$58.5MFY 2024$69.3MFY 2025$80.3M
$4.2M$80.3M

Free cash flow by year

2017 → 2025

FY 2017$-16.5MFY 2018$-21.5MFY 2019$-28.2MFY 2020$-24.6MFY 2021$-31.1MFY 2022$-42.6MFY 2023$-41.5MFY 2024$-42.6MFY 2025$-28.7M
-$16.5M-$28.7M

Gross margin by year

2021 → 2025

FY 202163.9%FY 202265.3%FY 202368.6%FY 202467.1%FY 202567.7%
63.9%67.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Incentive Plan AmendmentJun 11, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • 8-K eventDirector Resignations and AppointmentsApr 30, 2026Filing

Questions

Frequently asked questions

What is TELA Bio, Inc.'s market cap?

TELA Bio, Inc. (TELA) has a market capitalization of $42.5M.

What is TELA's P/E ratio?

A meaningful P/E ratio is not available for TELA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TELA's price-to-book (P/B) ratio?

TELA trades at 6.74 times book value per share.

Are insiders buying TELA stock?

SEC Form 4 filings show no open-market insider buys at TELA Bio, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

MYO

Myomo, Inc.

$41.5M

NSPR

InspireMD, Inc.

$43.9M

ARAY

Accuray Incorporated

$44.9M

POAS

Phaos Technology Holdings (Caym

$34.8M

NMTC

NeuroOne Medical Technologies Corporation

$32.5M

SRTS

Sensus Healthcare, Inc.

$53.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.